AMHD — HLK Biotec Holding Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.41m
Annual cashflow statement for HLK Biotec Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
1998 June 30th | 1999 June 30th | |
---|---|---|
Period Length: | 1 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG |
Status: | Final | Final |
Net Income/Starting Line | -0.08 | -1.04 |
Depreciation | ||
Non-Cash Items | 0.005 | 0.323 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | -0.039 | 0.267 |
Change in Prepaid Expenses | ||
Change in Payable / Accrued Expenses | ||
Cash from Operating Activities | -0.114 | -0.442 |
Other Investing Cash Flow Items | 0 | -0.312 |
Acquisition of Business | ||
Change in Net Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | 0 | -0.312 |
Financing Cash Flow Items | 0.015 | -0.064 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | 0.115 | 0.816 |
Net Change in Cash | 0.001 | 0.063 |